Clinical trial
Extracellular Vesicle Signaling in Obesity and Cardiometabolic Disease (EVOC)
NCT06408961 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extracellular Vesicle Signaling in Obesity and Cardiometabolic Disease (EVOC)
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 2, 2019
- Completion date
- July 1, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.